Oluchi Oke, M.D.

NPI 1124463211ActiveIndividual· Internal Medicine, Hematology & Oncology· Houston, TX

Internal Medicine, Hematology & Oncology (M.D.) in Houston, Texas, trained at University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (class of 2013). Their prescriptions cost Medicare Part D more than their services did: $1,073,731 for 399 claims, against $28,446 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 4 companies reporting payments in 2025, $476.11 in all, mostly food and beverage.

Overview

NPI	1124463211
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	May 3, 2013
Last updated in NPPES	Mar 17, 2018

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	R1840	TX
Student in an Organized Health Care Education/Training Program	390200000X	—	—

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	221
Services billed	361 across 13 procedure codes
Paid by Medicare	$28,446

Part D prescriptions in 2024

Prescriptions (claims)	399 · 672 30-day fills
Patients	118
Total drug cost	$1,073,731
Generic share	79% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
Graduation year	2013
Medicare specialty	Hematology/Oncology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth